My watch list  

Marburg multiple sclerosis

Marburg multiple sclerosis, also known as malignant, acute or fulminant multiple sclerosis, is considered one of the multiple sclerosis borderline diseases, which is a collection of diseases classified by some as MS variants and by others as different diseases. Other diseases in this group are Neuromyelitis optica (NMO), Balo concentric sclerosis and Schilder's disease.[1]

It took its name from Otto Marburg. It can be diagnosed in vivo with an MRI.[2]

It is usually lethal, but recently it has been found to be responsive to Mitoxantrone[3] and Alemtuzumab,[4] and it has also been responsive to autologous stem cells transplantation.[5]

See also


  1. ^ Fontaine B (2001). "Borderline forms of multiple sclerosis" (in French). Rev. Neurol. (Paris) 157 (8-9 Pt 2): 929-34. PMID 11787357.
  2. ^ In vivo MRI diagnosis
  3. ^ Responsiveness to Mitoxantrone
  4. ^ Alemtuzumab and craniotomy for severe acute demyelinating illness [1]
  5. ^ Kimiskidis VK, Sakellari I, Tsimourtou V, et al (2007). "Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcome". doi:10.1177/1352458507082604. PMID 17942513.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Marburg_multiple_sclerosis". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE